Depression and stigma among a sample of Egyptian adolescents with epilepsy and their impact on antiseizure medications adherence
Epilepsy & Behavior · 2024
DOI: 10.1016/j.yebeh.2024.110031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Nirmeen Kishk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Faculty of Medicine, Cairo University, Egypt. Electronic address: Nirmeenkishk@kasralainy.edu.eg. Hauptthemen laut MEDLINE: Epilepsy, Medication Adherence, Social Stigma, Anticonvulsants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: The lifetime prevalence of epilepsy varies between 3.5 and 10.7 per 1000 individuals in developed countries, and from 0.9 to 74.4 per 1000 individuals in Asia, sub-Saharan Africa, and Latin America. In adolescents, the prevalence of epilepsy is estimated to be 1.5 to 2%. PURPOSE: The purpose of this study was to examine the clinical characteristics of adolescents with epilepsy (AWE) and highlight the differences between childhood-onset epilepsy and adolescent-onset epilepsy. Additionally, the study aimed to assess the level of self-stigma and depression, as well as their impact on adherence to antiseizure medication (ASMs). METHODS: This cross-sectional study was conducted at the Epilepsy Clinic at Kasr Al-Ainy Hospitals. Patients underwent a thorough evaluation of their seizure history, as well as completed the Adherence to Refills and Medications Scale (ARMS), Kilifi Stigma Scale for Epilepsy (KSSE), and Patient Health Questionnaire-9 (PHQ-9) to assess depression. RESULTS: A total of 136 AWE were included in the study, consisting of 82 males and 54 females with a median age of 15 and an interquartile range of 13-17. Most patients (54 %) had focal onset seizures, while the remaining 46 % had generalized onset seizures. Of the total sample, 87 (64 %) achieved seizure control for at least one year and are currently taking ASMs. However, only 60 % of the patients were found to be adherent to their ASMs. Fourteen patients (17.2 %) met the criteria for drug-resistant epilepsy. Interestingly, patients with adolescent-onset epilepsy were significantly more adherent to their ASMs compared to those with childhood-onset epilepsy (P=0.01). Additionally, the adherent group had significantly lower scores on KSSE and PHQ-9 compared to the non-adherent group (P=
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology Department, Faculty of Medicine, Cairo University, Egypt. Electronic address: Nirmeenkishk@kasralainy.edu.eg.
- Neurology Department, Faculty of Medicine, Cairo University, Egypt. Electronic address: Rehab.m.hassan@kasralainy.edu.eg.
- Internal Medicine Department, Faculty of Medicine, Cairo University, Egypt. Electronic address: shereenalsawy@kasralainy.edu.eg.
- Neurology Department, Faculty of Medicine, Cairo University, Egypt.
- Neurology Department, Faculty of Medicine, Cairo University, Egypt. Electronic address: amro.fouad@kasralainy.edu.eg.
Zitieren
APA
Kishk, N., Magdy, R., El-Sawy, S., Soliman, N. A., & Mohamed Fouad, A. (2024). Depression and stigma among a sample of Egyptian adolescents with epilepsy and their impact on antiseizure medications adherence. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.110031
Vancouver
Kishk N, Magdy R, El-Sawy S, Soliman NA, Mohamed Fouad A. Depression and stigma among a sample of Egyptian adolescents with epilepsy and their impact on antiseizure medications adherence. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.110031
BibTeX
@article{Kishk2024,
author = {Kishk, Nirmeen and Magdy, Rehab and El-Sawy, Shereen and Soliman, Nourhan A and Mohamed Fouad, Amr},
title = {Depression and stigma among a sample of Egyptian adolescents with epilepsy and their impact on antiseizure medications adherence},
journal = {Epilepsy & Behavior},
year = {2024},
doi = {10.1016/j.yebeh.2024.110031}
}
EUVIMED